SkinVision Skin Cancer Risk App
US$ 7 Price in USD — free shipping included
Independent profile. MedikalDevice is not affiliated with its manufacturer. Specifications come from public manufacturer documentation — confirm FDA status for your intended use. How we verify profiles.
A smartphone app (software, not a hardware scanner) that analyzes a photo of a skin spot and gives a low- or high-risk indication for skin cancer, advising whether to see a doctor. Consumer use.
Key facts
| Product | SkinVision |
|---|---|
| Manufacturer | SkinVision B.V. (Amsterdam, Netherlands) |
| Intended users | Home / personal use |
| US FDA status | Not FDA-cleared (wellness/consumer) |
| Market status | Available |
Main features
- Uses the smartphone camera; no separate hardware
- Algorithm gives a low/high risk indication per skin spot
- CE-marked medical device app, EU MDR Class IIa (Aug 2025)
Connectivity
Smartphone app (iOS/Android) with cloud-based analysis.
AI and analysis software
AI image-analysis algorithm for skin lesion risk assessment.
Software outputs are an aid to the clinician, not a diagnosis, and are limited to the indications cleared for each feature.
Regulatory status in the United States
We found no FDA clearance or approval for this product. It should not be relied on for diagnosis in the United States. Not FDA-authorized; US pivotal trial with Mayo Clinic announced March 2026; app not available in the US.
Related guide: Dermatoscopes With Built-In AI.
Sources
- skinvision.com (manufacturer)
- skinvision.com
- prnewswire.com
Profile verified against public sources in October 2026. Trademarks belong to their owners.
